Quanli Xu
Papers
1
Total Citations
3
H-Index
1
About
Dr. Quanli Xu is an emerging leader in robotic hepatobiliary and pancreatic surgery, with a focused expertise in complex oncologic resections and vascular reconstructions. His primary research centers on advancing minimally invasive techniques for treating advanced liver and kidney cancers, particularly those involving tumor thrombus extension into the inferior vena cava (IVC). Dr. Xu’s most notable contribution is the development and validation of the robotic retrohepatic IVC thrombectomy using the caudate lobectomy technique, a novel approach that dramatically improves exposure and safety for level II-III tumor thrombi. His pioneering work, detailed in a 2025 publication, demonstrates the feasibility of this challenging procedure, offering a safer alternative to open surgery for select patients. While his career is still in its early stages, with his landmark paper already garnering 3 citations, this work represents a significant technical advance in a high-risk field. Dr. Xu’s research is poised to redefine the surgical management of renal cell carcinoma with IVC involvement, pushing the boundaries of what is achievable robotically.
Research Focus
Key Achievements
Top Papers
- 1